Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)
4 More presentations in this session
Associate Professor S. Girotra (Dallas, US)
Doctor Y. Zheng (Beijing, CN)
Ms D. van Vliet (Enschede, NL)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
